824 – Change in Cardiometabolic Risk Markers Following Switch to Integrase Inhibitors Differs by Sex
Background Integrase strand-transfer inhibitor (INSTI)-associated weight gain among people with HIV (PWH) is greater in women than men. We assessed sex differences in cardiometabolic markers up to 5 years following INSTI initiation. Methods We used data collected between 2007-2020 in INSTI-naïve PWH on antiretroviral therapy (ART) for ≥2 years with viral suppression (<200 c/mL) and…